The funny thing about NWBO is that the price continues to decline as we get closer and closer to unblinding. The price would indicate that as time goes on, the probability of the trial failing goes up. Yet the historical data has proven the opposite. Each blinded data reveal has given better data as time has elapsed. So, as we get closer to unblinding (I agree...the timing will shock the market), I expect data will be great based on history.
Unexpected positive trial results and fast track of approval could shock the market. How it affects the share price is unknown. We could go to $3, $5, or $55. But the longs would be in full control.
Until then, we just wait.